Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
Cilomni-10/40
Composition
Cilnidipine IP 10 mg and Telmisartan IP 40 mg, along with approved excipients
Dosage Strength
10 mg & 40 mg
Medicine Type
Tablet
Pack Size
10 X 10 Tablets
Storage Instructions
Cilomni-T 10/40 Cilnidipine and Telmisartan Tablets should be stored in a cool, dark, and dry place, protected from light and moisture.
Caution
The medicine must be kept out of reach of children and used only as directed by the physician.
Product Information
Cilomni-T 10/40 by EMK Omni Pharma is a prescription-based Cilnidipine and Telmisartan Tablets formulation used for doctor-supervised hypertension management, blood pressure control, and cardiovascular health support. Each film-coated tablet contains Cilnidipine IP 10 mg and Telmisartan IP 40 mg. Cilomni-T 10/40 is designed for patients who require combination therapy support for high blood pressure, vascular health, heart care, and long-term cardiovascular risk management. Cilomni-T 10/40 Cilnidipine 10 mg and Telmisartan 40 mg Tablets by EMK Omni Pharma are commonly prescribed by healthcare professionals as part of a physician-guided treatment plan for hypertension, elevated blood pressure, cardiac protection, and blood vessel relaxation support. This medicine should be used only under the supervision of a registered medical practitioner. Cilomni-T 10/40 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, vascular resistance, and cardiovascular risk factors. It may be used as part of a complete physician-guided heart care plan for individuals who need blood pressure control and long-term cardiovascular health management. Cilomni-T 10/40 by EMK Omni Pharma is suitable for doctor-supervised treatment where combination support for hypertension, blood pressure management, and cardiac health is required. Patients should not self-medicate, change the dosage, stop the medicine, or combine it with other medicines without consulting their doctor. Telmisartan should be discontinued as soon as pregnancy is detected, as advised on the product label, and patients must consult their physician immediately in such cases.
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.